findmyKOL

Daniel Libby, MD

Basic profile

Cornell University

ORCIDNone on fileNPI
RegionNew York, NY · NortheastSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Daniel Libby is a Respiratory physician affiliated with Cornell University. OpenAlex indexes 72 publications with 7,539 citations (h-index 35).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
72publications

Distinct works indexed by OpenAlex.

7,539citations

Total citations across indexed works.

35h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
18companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

407 E 70th St
New York, NY 100215311

Telephone

212-628-6611

Registry record last updated 8 Jul 2007.

View the NPPES registry record

Industry payments

18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    49.4%
    Corticosteroid29.1%
    Trelegy Ellipta57%Breo Ellipta22%Symbicort9%Arnuity Ellipta5%Fluticasone Propionate4%Qvar Redihaler3%
    Part D<11 patients
    beta2-Adrenergic Agonist9.9%
    Albuterol Sulfate Hfa78%Ventolin Hfa23%
    Part D<11 patients

    + 3 more classes in this area

  • Cardiovascular

    16.2%
    Statin9.7%
    Rosuvastatin Calcium53%Atorvastatin Calcium37%Simvastatin10%
    Part D<11 patients
    Calcium channel blocker2.4%
    Amlodipine Besylate100%
    Part D13 patients

    + 3 more classes in this area

  • Anti-infectives

    15.2%
    Macrolide Antimicrobial6.6%
    Azithromycin100%
    Part D56 patients
    Penicillins with extended spectrum2.9%
    Amoxicillin-Clavulanate Potass100%
    Part D28 patients

    + 4 more classes in this area

Where care is delivered (Part B), 20230% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”